{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:02Z","timestamp":1792791542648,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002369","name":"Chongqing University","doi-asserted-by":"publisher","award":["2023LJXM003"],"award-info":[{"award-number":["2023LJXM003"]}],"id":[{"id":"10.13039\/501100002369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002369","name":"Chongqing University","doi-asserted-by":"publisher","award":["2024LJXM001"],"award-info":[{"award-number":["2024LJXM001"]}],"id":[{"id":"10.13039\/501100002369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002369","name":"Chongqing University","doi-asserted-by":"publisher","award":["2023qdjfxm006"],"award-info":[{"award-number":["2023qdjfxm006"]}],"id":[{"id":"10.13039\/501100002369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018623","name":"Quanzhou City Science and Technology Program","doi-asserted-by":"publisher","award":["2025QZC02DW"],"award-info":[{"award-number":["2025QZC02DW"]}],"id":[{"id":"10.13039\/501100018623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["KJZD-M202300102"],"award-info":[{"award-number":["KJZD-M202300102"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2025MSXM075"],"award-info":[{"award-number":["2025MSXM075"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515011906"],"award-info":[{"award-number":["2023A1515011906"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0490"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0490"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J011787"],"award-info":[{"award-number":["2023J011787"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009047","name":"Shantou University","doi-asserted-by":"publisher","award":["NTF20030"],"award-info":[{"award-number":["NTF20030"]}],"id":[{"id":"10.13039\/100009047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010166","name":"Xiamen Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["Y20250070"],"award-info":[{"award-number":["Y20250070"]}],"id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111185","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:35:11Z","timestamp":1788950111000},"page":"111185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Opto-CRISPR technologies in translational neuropharmacology"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-0363","authenticated-orcid":false,"given":"Cia-Hin","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingle","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111185_bib1","doi-asserted-by":"crossref","DOI":"10.3791\/68779","article-title":"Rapid optimization of a light-inducible system to control Mammalian gene expression","author":"Abad Santos","year":"2025","journal-title":"J. Vis. Exp 225"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111185_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41551-023-01132-z","article-title":"Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophy","volume":"8","author":"Alves","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41377-025-02128-x","article-title":"Near infrared light controlled gene editing","volume":"15","author":"Berezin","year":"2026","journal-title":"Light Sci. Appl."},{"key":"10.1016\/j.neuropharm.2026.111185_bib4","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.97180.3","article-title":"Base editing of Ptbp1 in neurons alleviates symptoms in a mouse model of Parkinson's disease","volume":"13","author":"Bock","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2026.111185_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awag007","article-title":"Neuronal titration of Snca via enhancer disruption mitigates disease onset in a Parkinson's disease mouse model","author":"Boyd","year":"2026","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.neuropharm.2026.111185_bib6","article-title":"A versatile anti-CRISPR platform for opto- and chemogenetic control of CRISPR-Cas9 and Cas12 across a wide range of orthologs","volume":"53","author":"Brenker","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111185_bib7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s41592-018-0178-9","article-title":"Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9","volume":"15","author":"Bubeck","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2026.111185_bib8","article-title":"Engineered dCas12f1-SAM enables robust transcriptional activation and gain-of-function screening in primary human cells","author":"Cao","year":"2026","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib9","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1038\/s41467-020-18853-3","article-title":"CRISPRoff enables spatio-temporal control of CRISPR editing","volume":"11","author":"Carlson-Stevermer","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111185_bib10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s13287-021-02585-2","article-title":"In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation","volume":"12","author":"Chang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111185_bib12","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1016\/j.apsb.2025.07.010","article-title":"Spatiotemporally delivery of Cas9 ribonucleoprotein\/DNAzyme logic systems using near-infrared upconversion nanomachine for precise immunotherapy","volume":"15","author":"Chen","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111185_bib13","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1073\/pnas.1912220117","article-title":"Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing","volume":"117","author":"Chen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111185_bib14","article-title":"NIR-II biomimetic nanoplatform optogenetic CD274 editing of HNSCC immunogenicity for enhanced photoimmunotherapy","volume":"37","author":"Chen","year":"2026","journal-title":"Mater. Today Bio"},{"issue":"13","key":"10.1016\/j.neuropharm.2026.111185_bib15","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1523\/JNEUROSCI.1802-22.2022","article-title":"Inducible CRISPR epigenome systems Mimic Cocaine induced bidirectional regulation of Nab2 and Egr3","volume":"43","author":"Choi","year":"2023","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111185_bib16","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41565-024-01694-2","article-title":"In vivo magnetogenetics for cell-type-specific targeting and modulation of brain circuits","volume":"19","author":"Choi","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111185_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aea8052","article-title":"Self-inactivating AAV-CRISPR at different ages enables sustained amelioration of Huntington's disease deficits in BAC226Q mice","volume":"12","author":"Dai","year":"2026","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111185_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/01616412.2025.2529560","article-title":"Alzheimer's disease basics: we all should know","volume":"48","author":"Das","year":"2026","journal-title":"Neurol. Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111185_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1382","article-title":"Split-Cas9-based targeted gene editing and nanobody-mediated proteolysis-targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells","volume":"13","author":"Deng","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111185_bib20","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1093\/nar\/gkad178","article-title":"G-quadruplex-based CRISPR photoswitch for spatiotemporal control of genomic modulation","volume":"51","author":"Deng","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"3\u20134","key":"10.1016\/j.neuropharm.2026.111185_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41434-019-0116-1","article-title":"The deletion of mutant SOD1 via CRISPR\/Cas9\/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"27","author":"Duan","year":"2020","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111185_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4062\/biomolther.2025.022","article-title":"RNA therapeutics: focus on antisense oligonucleotides in the nervous System","volume":"33","author":"Ertural","year":"2025","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.neuropharm.2026.111185_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2026.02.023","article-title":"Microglia-mediated protection against Alzheimer's disease pathology and detrimental effects in white matter revealed by Ptpn6 deletion","author":"Etxeberria","year":"2026","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111185_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102317","article-title":"Cas9 editing of ATXN1 in a spinocerebellar ataxia type 1 mice and human iPSC-derived neurons","volume":"35","author":"Fagan","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"819","key":"10.1016\/j.neuropharm.2026.111185_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adq3551","article-title":"CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice","volume":"17","author":"Geng","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111185_bib26","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1038\/s41593-025-02094-y","article-title":"APOE4 to APOE2 allelic switching in mice improves Alzheimer's disease-related metabolic signatures, neuropathology and cognition","volume":"28","author":"Golden","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-026-04917-6","article-title":"Forward programming of human pluripotent stem cells to generate glutamatergic and GABAergic neurons in a tri-culture model with astrocytes","volume":"17","author":"Gu","year":"2026","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.neuropharm.2026.111185_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jare.2024.07.018","article-title":"CRISPR\/Cas9-mediated neuronal deletion of 5-lipoxygenase alleviates deficits in mouse models of epilepsy","volume":"63","author":"Guan","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.neuropharm.2026.111185_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.omtn.2021.02.032","article-title":"Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD in vitro","volume":"24","author":"Guyon","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.neuropharm.2026.111185_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/bs.apcsb.2025.08.017","article-title":"Small molecule inhibitors targeting alpha-synuclein aggregation: progress and future outlook","volume":"148","author":"Hajam","year":"2025","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"759","key":"10.1016\/j.neuropharm.2026.111185_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi4830","article-title":"Engineered exosomes with a photoinducible protein delivery system enable CRISPR-Cas-based epigenome editing in Alzheimer's disease","volume":"16","author":"Han","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib32","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1038\/s41467-024-50095-5","article-title":"Therapeutic strategy for spinal muscular atrophy by combining gene supplementation and genome editing","volume":"15","author":"Hatanaka","year":"2024","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.neuropharm.2026.111185_bib33","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1021\/ja512664v","article-title":"Optical control of CRISPR\/Cas9 gene editing","volume":"137","author":"Hemphill","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111185_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa1198","article-title":"Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein","volume":"49","author":"Hoffmann","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib35","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1038\/s41467-025-61094-5","article-title":"Scalable modulation of CRISPR\u2012Cas enzyme activity using photocleavable phosphorothioate DNA","volume":"16","author":"Hu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111185_bib36","article-title":"Opto-CRISPR: new prospects for gene editing and regulation","author":"Huang","year":"2025","journal-title":"Trends Biotechnol."},{"issue":"40","key":"10.1016\/j.neuropharm.2026.111185_bib37","doi-asserted-by":"crossref","first-page":"12440","DOI":"10.1002\/anie.201606123","article-title":"Development of light-activated CRISPR using guide RNAs with photocleavable protectors","volume":"55","author":"Jain","year":"2016","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111185_bib38","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/acs.nanolett.5c05621","article-title":"Near-infrared light-inducible CRISPR-Cas12a\/Tetrahedral DNA nanosystem for spatiotemporal control of mtDNA mutation imaging and gene therapy","volume":"26","author":"Jiang","year":"2026","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41467-024-55550-x","article-title":"Dual-targeting CRISPR-CasRx reduces C9orf72 ALS\/FTD sense and antisense repeat RNAs in vitro and in vivo","volume":"16","author":"Kempthorne","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111185_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111508","article-title":"Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2","volume":"41","author":"Kim","year":"2022","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111185_bib41","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/j.cell.2026.03.029","article-title":"Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression","volume":"189","author":"Kim","year":"2026","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111185_bib42","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.stem.2023.05.015","article-title":"Advanced human iPSC-based preclinical model for Parkinson's disease with optogenetic alpha-synuclein aggregation","volume":"30","author":"Kim","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111185_bib43","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1021\/acsnano.3c05864","article-title":"Ultrasound-assisted CRISPRi-Exosome for epigenetic modification of alpha-Synuclein gene in a mouse model of Parkinson's Disease","volume":"18","author":"Kong","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.neuropharm.2026.111185_bib44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.omtn.2019.04.015","article-title":"Targeted transgene activation in the brain tissue by systemic delivery of engineered AAV1 expressing CRISPRa","volume":"16","author":"Lau","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.neuropharm.2026.111185_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12703\/r\/9-20","article-title":"CRISPR-based strategies for targeted transgene knock-in and gene correction","volume":"9","author":"Lau","year":"2020","journal-title":"Fac. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111185_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11248-024-00404-x","article-title":"Next-generation CRISPR technology for genome, epigenome and mitochondrial editing","volume":"33","author":"Lau","year":"2024","journal-title":"Transgenic Res."},{"key":"10.1016\/j.neuropharm.2026.111185_bib46","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.12688\/f1000research.11243.1","article-title":"In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease","volume":"6","author":"Lau","year":"2017","journal-title":"F1000Res"},{"issue":"3\u20134","key":"10.1016\/j.neuropharm.2026.111185_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00335-017-9727-2","article-title":"CRISPR-based strategies for studying regulatory elements and chromatin structure in mammalian gene control","volume":"29","author":"Lau","year":"2018","journal-title":"Mamm. Genome"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111185_bib48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11248-018-0096-8","article-title":"In vivo epigenome editing and transcriptional modulation using CRISPR technology","volume":"27","author":"Lau","year":"2018","journal-title":"Transgenic Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111185_bib49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/1566523219666190701100556","article-title":"The synergy between CRISPR and chemical engineering","volume":"19","author":"Lau","year":"2019","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.neuropharm.2026.111185_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.124119","article-title":"Extracellular vesicles-mediated delivery of SpCas9 RNPs for therapeutic gene editing in Spinocerebellar Ataxia Type 3","volume":"331","author":"Leandro","year":"2026","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111185_bib52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41551-018-0252-8","article-title":"Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours","volume":"2","author":"Lee","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111185_bib53","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1039\/D0NR06765B","article-title":"Targeted brain tumor imaging by using discrete biopolymer-coated nanodiamonds across the blood-brain barrier","volume":"13","author":"Leung","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.neuropharm.2026.111185_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2026.107419","article-title":"Humanized mice carrying a pathogenic GRN deletion as a pre-clinical platform for targeted gene therapies in frontotemporal dementia","volume":"224","author":"Life","year":"2026","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-024-00794-w","article-title":"RNA-targeting CRISPR\/CasRx system relieves disease symptoms in Huntington's disease models","volume":"20","author":"Lin","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib56","article-title":"Target-stabilized base editors enable robust high-fidelity RNA editing","volume":"17","author":"Liu","year":"2026","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111185_bib57","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2018.01.012","article-title":"Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41583-018-0088-y","article-title":"Rhythms of life: circadian disruption and brain disorders across the lifespan","volume":"20","author":"Logan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111185_bib59","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s11434-015-0902-0","article-title":"Magnetogenetics: remote non-invasive magnetic activation of neuronal activity with a magnetoreceptor","volume":"60","author":"Long","year":"2015","journal-title":"Sci Bull (Beijing)"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111185_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091507","article-title":"Biased and unbiased methods for the detection of off-target cleavage by CRISPR\/Cas9: an overview","volume":"17","author":"Martin","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib61","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1038\/s41467-020-17954-3","article-title":"Frataxin gene editing rescues Friedreich's ataxia pathology in dorsal root ganglia organoid-derived sensory neurons","volume":"11","author":"Mazzara","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib62","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1038\/s41467-024-47485-0","article-title":"Splice modulators target PMS1 to reduce somatic expansion of the Huntington's disease-associated CAG repeat","volume":"15","author":"McLean","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib63","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1038\/s41467-022-33332-7","article-title":"CRISPR\/Cas9-mediated excision of ALS\/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro","volume":"13","author":"Meijboom","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41593-022-01207-1","article-title":"An RNA-targeting CRISPR-Cas13d system alleviates disease-related phenotypes in Huntington's disease models","volume":"26","author":"Morelli","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111185_bib65","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/acscentsci.9b01093","article-title":"Photoswitchable gRNAs for spatiotemporally controlled CRISPR-Cas-Based genomic regulation","volume":"6","author":"Moroz-Omori","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111185_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2026.102896","article-title":"Exosome-like nanovesicles from acerola for CRISPR-Cas9 ribonucleoprotein delivery to the central nervous system","volume":"37","author":"Nagamatsu","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2026.111185_bib67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41434-023-00414-0","article-title":"CRISPR\/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson s disease","volume":"31","author":"Narvaez-Perez","year":"2024","journal-title":"Gene Ther."},{"key":"10.1016\/j.neuropharm.2026.111185_bib68","article-title":"LUCas: Light-Uncaged Cas13a using photocleavable interfering guide RNAs","author":"Ng","year":"2026","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111185_bib69","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nbt.3245","article-title":"Photoactivatable CRISPR-Cas9 for optogenetic genome editing","volume":"33","author":"Nihongaki","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111185_bib70","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70445","article-title":"Antisense oligonucleotides in Parkinson's Disease: challenges, opportunities, and the promise of low-intensity focused ultrasound for brain delivery","volume":"170","author":"Obika","year":"2026","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2026.111185_bib71","article-title":"Somatic CRISPR editing of Msh3 mitigates Huntington's disease pathology in mice","author":"Oliver","year":"2026","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111185_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2026.104350","article-title":"Therapeutic monoclonal antibodies in the central nervous system: pharmacokinetics, bioanalysis and clinical implications","volume":"115","author":"Onyango","year":"2026","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.neuropharm.2026.111185_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2026.1766762","article-title":"Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer's disease therapy","volume":"14","author":"Ouro","year":"2026","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111185_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav7199","article-title":"Near-infrared upconversion-activated CRISPR-Cas9 system: a remote-controlled gene editing platform","volume":"5","author":"Pan","year":"2019","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111185_bib75","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease","volume":"22","author":"Park","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111185_bib76","article-title":"CRISPRa lipid nanocomplex-mediated Mt3 targeting enhances astrocytic endocytosis of amyloid-beta in an Alzheimer's Disease mouse model","volume":"13","author":"Park","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111185_bib77","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7150\/thno.103455","article-title":"Targeted demethylation of cathepsin D via epigenome editing rescues pathology in Alzheimer's disease mouse model","volume":"15","author":"Park","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.neuropharm.2026.111185_bib78","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jconrel.2024.11.029","article-title":"Modulation of GABAergic neurons in acute epilepsy using sonogenetics","volume":"377","author":"Phan","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.neuropharm.2026.111185_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104785","article-title":"Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations","volume":"138","author":"Pimenova","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111185_bib80","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nchembio.1753","article-title":"A light-inducible CRISPR-Cas9 system for control of endogenous gene activation","volume":"11","author":"Polstein","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111185_bib81","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.chembiol.2024.09.006","article-title":"Reducing CRISPR-Cas9 off-target effects by optically controlled chemical modifications of guide RNA","volume":"31","author":"Qi","year":"2024","journal-title":"Cell Chem. Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111185_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/JCI196402","article-title":"Base editing rescues seizures and sudden death in a SCN8A mutation-associated developmental epileptic encephalopathy model","volume":"136","author":"Reever","year":"2026","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111185_bib83","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.stem.2020.10.015","article-title":"CRISPR-Mediated induction of neuron-enriched mitochondrial proteins boosts direct Glia-to-Neuron conversion","volume":"28","author":"Russo","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111185_bib84","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41434-025-00557-2","article-title":"Gene editing for Spinocerebellar ataxia type 3 taking advantage of the human ATXN3L paralog as replacement gene","volume":"32","author":"Rybarikova","year":"2025","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111185_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102728","article-title":"Targeting AASS alleviates neurotoxicity and improves mitochondrial function in astrocyte models for pyridoxine-dependent epilepsy","volume":"36","author":"Schuurmans","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"29","key":"10.1016\/j.neuropharm.2026.111185_bib86","doi-asserted-by":"crossref","first-page":"E6722","DOI":"10.1073\/pnas.1802448115","article-title":"Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation","volume":"115","author":"Shao","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111185_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.150047","article-title":"Next-generation neurotherapeutics: mechanistic insights on monoclonal antibodies in Alzheimer's disease","volume":"1870","author":"Sharma","year":"2026","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ana.26656","article-title":"CRISPR-Based KCC2 upregulation attenuates drug-resistant seizure in mouse models of epilepsy","volume":"94","author":"Shi","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111185_bib89","article-title":"In vivo CRISPR base editing for treatment of Huntington's disease","author":"Shirguppe","year":"2024","journal-title":"bioRxiv"},{"issue":"21","key":"10.1016\/j.neuropharm.2026.111185_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202401004","article-title":"Near-Infrared light activated formulation for the spatially controlled release of CRISPR-Cas9 ribonucleoprotein for brain gene editing","volume":"63","author":"Simoes","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111185_bib91","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkag113","article-title":"Engineering a human-based translational activator for targeted protein expression restoration","volume":"54","author":"Sinnott","year":"2026","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2026.111185_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1153681","article-title":"Editorial: viral vector-based gene therapy in neurological disease: the future is now","volume":"14","author":"Smith","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib93","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41467-018-07971-8","article-title":"CRISPR\/Cas9 editing of APP C-terminus attenuates beta-cleavage and promotes alpha-cleavage","volume":"10","author":"Sun","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111185_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2026.04.038","article-title":"Treatment of Huntington's disease with a pan-HTT-targeting CRISPR nuclease","author":"Tan","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuropharm.2026.111185_bib95","doi-asserted-by":"crossref","DOI":"10.1177\/18796397251415368","article-title":"Silencing of human HTT by targeted CRISPR\/dCas9-mediated epigenetic editing","author":"Tay","year":"2026","journal-title":"J. Huntingtons. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib96","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1038\/s41467-025-62082-5","article-title":"Identification of a key nucleotide influencing Cas12a crRNA activity for universal photo-controlled CRISPR diagnostics","volume":"16","author":"Tian","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib97","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/crispr.2021.0085","article-title":"Insertion of the Icelandic mutation (A673T) by prime editing: a potential preventive treatment for familial and sporadic Alzheimer's Disease","volume":"5","author":"Tremblay","year":"2022","journal-title":"CRISPR J."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2021.10.029","article-title":"Central nervous system regeneration","volume":"185","author":"Varadarajan","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib99","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41467-025-68183-5","article-title":"A compact and inducible dCas12f-based CRISPRa platform for programmable in vivo gene activation","volume":"17","author":"Wan","year":"2026","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111185_bib100","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/acschembio.0c00105","article-title":"Light-Driven activation of RNA-Guided nucleic acid cleavage","volume":"15","author":"Wang","year":"2020","journal-title":"ACS Chem. Biol."},{"issue":"50","key":"10.1016\/j.neuropharm.2026.111185_bib101","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2358","article-title":"A far-red light-inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation","volume":"7","author":"Wang","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib102","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s13287-024-03921-y","article-title":"Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson's disease","volume":"15","author":"Wang","year":"2024","journal-title":"Stem Cell Res. Ther."},{"issue":"22","key":"10.1016\/j.neuropharm.2026.111185_bib103","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220575120","article-title":"Modulation of deep neural circuits with sonogenetics","volume":"120","author":"Xian","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"26","key":"10.1016\/j.neuropharm.2026.111185_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202320029","article-title":"Small molecule-inducible and photoactivatable cellular RNA N1-Methyladenosine editing","volume":"63","author":"Xie","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111185_bib105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41551-023-01007-3","article-title":"Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington's disease","volume":"7","author":"Yan","year":"2023","journal-title":"Nat. Biomed. Eng."},{"issue":"32","key":"10.1016\/j.neuropharm.2026.111185_bib106","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1021\/acs.nanolett.4c02272","article-title":"A nanozyme-boosted MOF-CRISPR platform for treatment of Alzheimer's Disease","volume":"24","author":"Yang","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.neuropharm.2026.111185_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1019412","article-title":"Small-molecule drugs development for Alzheimer's disease","volume":"14","author":"Yao","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib108","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41467-024-44867-2","article-title":"Programmable RNA base editing with photoactivatable CRISPR-Cas13","volume":"15","author":"Yu","year":"2024","journal-title":"Nat. Commun."},{"issue":"28","key":"10.1016\/j.neuropharm.2026.111185_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb1777","article-title":"Engineering a far-red light-activated split-Cas9 system for remote-controlled genome editing of internal organs and tumors","volume":"6","author":"Yu","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111185_bib110","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1038\/s41467-023-42147-z","article-title":"Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins","volume":"14","author":"Zeballos","year":"2023","journal-title":"Nat. Commun."},{"issue":"47","key":"10.1016\/j.neuropharm.2026.111185_bib111","doi-asserted-by":"crossref","first-page":"20895","DOI":"10.1002\/anie.202009890","article-title":"Optical control of a CRISPR\/Cas9 System for gene editing by using photolabile crRNA","volume":"59","author":"Zhang","year":"2020","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.neuropharm.2026.111185_bib112","article-title":"Photoactivatable CRISPR\/Cas13d via upconversion nanoparticles for deep tissue RNA engineering and orthopedic therapy","author":"Zhao","year":"2026","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111185_bib113","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cell.2020.03.024","article-title":"Glia-to-Neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice","volume":"181","author":"Zhou","year":"2020","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.neuropharm.2026.111185_bib114","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1002\/anie.201914575","article-title":"Spatiotemporal control of CRISPR\/Cas9 function in cells and zebrafish using light-activated guide RNA","volume":"59","author":"Zhou","year":"2020","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"6327","key":"10.1016\/j.neuropharm.2026.111185_bib115","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1126\/science.aah3605","article-title":"Optical control of cell signaling by single-chain photoswitchable kinases","volume":"355","author":"Zhou","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.111185_bib116","article-title":"Multimodal control of Cas13d activity through domain insertion at an allosteric hotspot","author":"Zhu","year":"2026","journal-title":"Nat. Commun."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:53:48Z","timestamp":1792788828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":116,"alternative-id":["S0028390826003606"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111185","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opto-CRISPR technologies in translational neuropharmacology","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111185"}}